| Literature DB >> 27818369 |
Jean-Claude Souberbielle1, Claude Laurent Benhamou2, Bernard Cortet3, Mickael Rousière4, Christian Roux5, Vered Abitbol6, Cédric Annweiler7, Maurice Audran8, Justine Bacchetta9, Pierre Bataille10, Olivier Beauchet7, Rémi Bardet11, Alexandra Benachi12, Francis Berenbaum13, Hubert Blain14, Françoise Borson-Chazot15, Véronique Breuil16, Karine Briot5, Philippe Brunet17, Jean-Claude Carel18, Philippe Caron19, Olivier Chabre20, Philippe Chanson21, Roland Chapurlat22, Pierre Cochat9, Régis Coutant23, Sophie Christin-Maitre24, Martine Cohen-Solal25, Christian Combe26, Catherine Cormier27, Marie Courbebaisse28, Grégory Debrus29, Brigitte Delemer30, Georges Deschenes31, Marc Duquenne32, Guillaume Duval7, Patrice Fardellone33, Denis Fouque34, Gérard Friedlander35, Jean-Bernard Gauvain36, Lionel Groussin37, Pascal Guggenbuhl38, Pascal Houillier28, Thierry Hannedouche39, William Jacot40, Rose-Marie Javier41, Guillaume Jean42, Claude Jeandel43, Dominique Joly44, Peter Kamenicky21, Bertrand Knebelmann44, Marie-Hélène Lafage-Proust45, Yves LeBouc46, Erick Legrand8, Florence Levy-Weil47, Agnès Linglart48, Laurent Machet49, Emmanuel Maheu4, Eric Mallet50, Christian Marcelli51, Pierre Marès52, Christophe Mariat53, Gérard Maruani28, Yves Maugars54, France Montagnon55, Bruno Moulin39, Philippe Orcel25, Henri Partouche56, Virginie Personne56, Charles Pierrot-Deseilligny57, Michel Polak58, Claire Pouteil-Noble59, Dominique Prié1, Agathe Raynaud-Simon60, Yves Rolland61, Jean-Louis Sadoul62, Bernard Salle63, Corinne Sault64, Anne-Marie Schott65, Isabelle Sermet-Gaudelus66, Martin Soubrier67, Ivan Tack68, Eric Thervet69, Isabelle Tostivint70, Philippe Touraine71, Florence Tremollières72, Pablo Urena-Torres73, Jean-Paul Viard74, Jean-Louis Wemeau75, Georges Weryha76, Norbert Winer77, Jacques Young21, Thierry Thomas45.
Abstract
The number of serum 25-hydroxyvitamin D (25OHD) assays has increased tenfold in France in less than 10 years, sometimes for invalidated reasons. In 2013, the French National Authority for Health (Haute autorité de santé, or HAS) limited the indications for serum 25OHD measurements to rickets/osteomalacia, older adults with recurrent falls, monitoring of kidney transplant in adults, and surgical treatment of obesity in adults. Our aim here was to note that other indications for serum 25OHD measurements are supported by previous literature and by a number of national and international recommendations, in particular the following: any situation of bone fragility, any chronic renal failure <45 mL/min/1.73m2, any situation of malabsorption, clinical signs consistent with vitamin D deficiency or vitamin D overload, and calcium phosphorus evaluation. We suggest that the measurement of serum 25OHD concentration should remain reimbursed as part of these extended indications.Entities:
Keywords: France; assay; calcium phosphorus evaluation; chronic kidney disease; clinical practice; osteomalacia; osteoporosis; recommendation; reimbursement; rickets; vitamin D
Mesh：
Substances：
Year: 2016 PMID： 27818369 DOI： 10.1684/pnv.2016.0631
Source DB: PubMed Journal: Geriatr Psychol Neuropsychiatr Vieil ISSN： 2115-7863